Approval · Notice of Compliance 17940 · 2016
MILBEMAX: Notice of Compliance 17940
Issued March 29, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17940
- Date
- March 29, 2016
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MILBEMAX | 02291959 | Marketed |
Medicinal ingredients
- MILBEMYCIN OXIME 16 MG per TAB
- PRAZIQUANTEL 40 MG per TAB